Study of effects of antiepileptic therapy on various biochemical and hematological parameters patients suffering of epilepsy


  • Uma A. Bhosale Department of Pharmacology, Smt. Kashibai Navale Medical College and General Hospital, Narhe (Ambegaon) - 411 041, Pune, India
  • Neha R. Loharkar Department of Pharmacology, Smt. Kashibai Navale Medical College and General Hospital, Narhe (Ambegaon) - 411 041, Pune, India
  • Radha Yegnanarayan Department of Pharmacology, Smt. Kashibai Navale Medical College and General Hospital, Narhe (Ambegaon) - 411 041, Pune, India
  • Nilofar Quraishi Department of Pharmacology, Smt. Kashibai Navale Medical College and General Hospital, Narhe (Ambegaon) - 411 041, Pune, India


Antiepileptics, Pharmacovigilance, Monotherapy, Combinations


Background: Low therapeutic index of established antiepileptic drugs (AEDs) coupled with better understanding of the pathophysiology of seizure has encouraged the development of several novel AEDs. The conventional antiepileptics like phenytoin, phenobarbitone, valproate and carbamazepine and newer antiepileptics like levetiracetam, lamotrigine and topiramate etc. are used for epilepsy. AEDs induce potentially toxic effects over a period of time which remains undetermined over very long time. Earlier studies in this regard, states uneven results about biochemical (i.e. blood sugar level, lipid profile) and hematological (Hb%, blood cell count etc.) toxicity of AEDs. Aims: To unveil the toxic effects of AEDs when given singly or as combinations.

Methods: Adult epileptics of either sex taking antiepileptic monotherapy or combination therapy for ≥ six months were enrolled. Biochemical and hematological parameters studied were compared with their age and sex matched controls, baseline and amongst groups. Statistical Analysis Used: Student’s ‘t’-test & One way ANOVA followed by posthoc Tukey HSD test for pair wise comparison; p<0.05 was considered significant.

Results: Conventional antiepileptic combination therapy was found more toxic; p<0.01 for lipid profile. Combination groups showed significant reduction in Hb% (p<0.05) with no significant difference among them (p>0.05). Monotherapy and conventional combination therapy caused significant reduction in platelet count (p<0.01), but conventional combination therapy was found more toxic in this regard (p<0.05).

Conclusions: Monotherapy found less toxic with no significant effects on lipid profile, Hb%, RBC count and O2 carrying capacity and less impact on platelets while combination therapy did not show any advantage over monotherapy and its use must be reserved only for refractory cases.



Shobhana Mathur, Sumana Sen, L Ramesh, Satish Kumar M. Utilization pattern of anntiepileptic drugs and their adverse effects, in a teaching hospital. Asian Journal of Pharmaceutical and Clinical Research. 2010;3(1):55-9.

Annegers, J.F.; Hauser, W.A. & Shirts, S.B. Heart disease mortality and morbidity in patients with epilepsy. Epilepsia. 1984;25:699-704.

Rai Yogesh, Kumar, Misra Harsh, Misra Asha. Effect of anticonvulsant drugs on lipid profile in epileptic patients. Indian Journal of Public Health Research & Development. 2010;1(1):46-50.

Manisha Naithani, Sunny Chopra, B L Somani, R K Singh, Shri Guru Ram Rai, Patel Nagar. Studies on adverse metabolic effects of antiepileptic and their correlation with blood components. Current Neurobiology. 2010;1(2):117-20.

Demir E, Aysun S. Weight gain associated with valproate in childhood. Pediatr Neurol. 2000;22:361-4.

Carter BL, Small RE, Mandel MD, Starkman MT. Phenytoin-induced hyperglycemia. Am J Hosp Pharm. 1981;38(10):1508-12.

Jawad S, Mercer A, Jamil N, Richens A. Haematological values of epileptic patients entering drug trials. International Journal of Clinical Pharmacology Research. 1988;8(5):363-6.

Pee DH, Park YK, Eun BL, Park SH, Kim SK. The Hematologic Effect of Antiepileptic Drugs. J Korean Pediatr Soc. 1997 Feb; 40(2):217-224.

Guyton AC, Hall JE. Text Book of Medical Physiology. 11th ed. Elsevier; New Delhi. 2006: 419-468.

Mintzer S, Skidmore CT, Abidin CJ, Morales MC, Chervoneva I, Capuzzi DM, Sperling MR. Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein. Ann Neurol. 2009;65(4):448-56.

Mintzer S. Metabolic consequences of antiepileptic drugs. Curr Opin Neurol. 2010;23(2):164-9.

Nebert, D.W. Russel, D.W. Clinical importance of the cytochromes P450. Lancet. 2002;360:1155-62.

Gibbons, G.F. The role of cytochrome P450 in the regulation of cholesterol biosynthesis. Lipids. 2002;37:1163-70.

Al-Rubeaan K, Ryan EA. Phenytoin-induced insulin insensitivity. Diabet Med. 1991;8(10):968-70.

Verotti, A.; Manco, R.; Agostinelli, S. et al. The metabolic syndrome in overweight epileptic patients treated with valproic acid. Epilepsia. 2010;51(2): 268-73.

Kamen B. Folate and antifolate pharmacology. Semin. Oncol. 1997;24(5):S18–30–9.

Koby Brosh, Ilan Matok, Eyal Sheiner, Gideon Koren, Arnon Wiznitzer, Rafael Gorodischer, Amalia Levy. Teratogenic Determinants of First- Trimester Exposure to Antiepileptic Medications. J Popul Ther Clin Pharmacol. 2011;18(1):e89-98.

Bailey SW, Ayling JE. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proceedings of the National Academy of Sciences of the United States of America. 2009;106 (36):15424–9.

Weinstein SJ, Hartman TJ, Stolzenberg-Solomon R, et al. Null association between prostate cancer and serum folate, vitamin B(6), vitamin B(12), and homocysteine. Cancer Epidemiol. Biomarkers Prev. 2003;12 (11 Pt 1):1271–2.

Selhub, J. Homocysteine metabolism. Annual Review of Nutrition. 1999;19:217–46.

Bachmann T, Bertheussen KH, Svalheim S, Rauchenzauner M, Luef G, Gjerstad L, Taubøll E. Haematological side effects of antiepileptic drug treatment in patients with epilepsy. Acta Neurol Scand Suppl. 2011;91:23-7.

Handoko KB, Souverein PC, van Staa TP, Meyboom RH, Leufkens HG, Egberts TC, vanden Bemt PM: Risk of aplastic anemia in patients using antiepileptic drugs. Epilepsia. 2006;47:1232–6.

Farkas V, Szabó M, Rényi I, Kohlhéb O, Benninger C: Temporary pure red-cell aplasia during valproate monotherapy: clinical observations and spectral electroencephalographic aspects. J Child Neurol. 2000;15:485–7.

Seung Hee Jang, Eun Kyoung Choi, So Hee Eun, Sun Jun Kim Changes of Body Weight and Lipid Profiles According to Apolipoprotein E Polymorphism in Children with Antiepileptics. J Korean Pediatr Soc. 2002;45:88-94.

Raman Sankar. Initial treatment of epilepsy with antiepileptic drugs. Neurology 2004;63(4):S30–9.

Hadiza Aliyu, Joseph O. Ayo Suleiman F. Ambali, Abdulkadir U. Zezi. Effects of administration of carbamazepine and/or phenytoin on haematological parameters in wistar rats. African Journal of Pharmacy and Pharmacology. 2013;7(23):1585-91.

Kramer MA, Cash SS. Epilepsy as a disorder of cortical network organization. Neuroscientist. 2012;18:360 72.

Johannessen SI, Landmark CJ. Antiepileptic drug interactions principles and clinical implications. Curr Neuropharmacol. 2010;8:254 67.




How to Cite

Bhosale, U. A., Loharkar, N. R., Yegnanarayan, R., & Quraishi, N. (2017). Study of effects of antiepileptic therapy on various biochemical and hematological parameters patients suffering of epilepsy. International Journal of Basic & Clinical Pharmacology, 3(1), 79–85. Retrieved from



Original Research Articles